IL116456A0 - Oligonucleotide-dendrimer conjugates - Google Patents

Oligonucleotide-dendrimer conjugates

Info

Publication number
IL116456A0
IL116456A0 IL11645695A IL11645695A IL116456A0 IL 116456 A0 IL116456 A0 IL 116456A0 IL 11645695 A IL11645695 A IL 11645695A IL 11645695 A IL11645695 A IL 11645695A IL 116456 A0 IL116456 A0 IL 116456A0
Authority
IL
Israel
Prior art keywords
oligonucleotide
dendrimer conjugates
dendrimer
conjugates
Prior art date
Application number
IL11645695A
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL116456A0 publication Critical patent/IL116456A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
IL11645695A 1994-12-21 1995-12-19 Oligonucleotide-dendrimer conjugates IL116456A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH385494 1994-12-21
CH4795 1995-01-09

Publications (1)

Publication Number Publication Date
IL116456A0 true IL116456A0 (en) 1996-03-31

Family

ID=25683356

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11645695A IL116456A0 (en) 1994-12-21 1995-12-19 Oligonucleotide-dendrimer conjugates

Country Status (9)

Country Link
EP (1) EP0790837A1 (en)
JP (1) JPH10510822A (en)
AU (1) AU4344696A (en)
CA (1) CA2206915A1 (en)
FI (1) FI972548A (en)
HU (1) HUT77521A (en)
IL (1) IL116456A0 (en)
NO (1) NO972868L (en)
WO (1) WO1996019240A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563255A (en) * 1994-05-31 1996-10-08 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of raf gene expression
US5744460A (en) * 1996-03-07 1998-04-28 Novartis Corporation Combination for treatment of proliferative diseases
AU745309B2 (en) * 1997-05-28 2002-03-21 Peter E. Nielsen Conjugated peptide nucleic acids having enhanced cellular uptake
GB9718129D0 (en) 1997-08-27 1997-10-29 Isis Innovation Branched structures
US6287765B1 (en) * 1998-05-20 2001-09-11 Molecular Machines, Inc. Methods for detecting and identifying single molecules
FR2906532B1 (en) 2006-09-28 2008-12-12 Biomerieux Sa NEW OLIGONUCLEOTIDE BRAND
FR2933410B1 (en) 2008-07-04 2010-08-20 Biomerieux Sa NEW DETECTION PROBE
TW202043256A (en) 2019-01-10 2020-12-01 美商健生生物科技公司 Prostate neoantigens and their uses
JP2023509571A (en) 2019-11-18 2023-03-09 ヤンセン バイオテツク,インコーポレーテツド Vaccines based on mutant CALR and JAK2 and uses thereof
CN112898575B (en) * 2019-12-03 2022-10-21 深圳清华大学研究院 Preparation method of crotch-like macromolecule modified nucleotide
CN112898580B (en) * 2019-12-03 2022-11-08 安序源生物科技(深圳)有限公司 Sequencing reagent
WO2022009052A2 (en) 2020-07-06 2022-01-13 Janssen Biotech, Inc. Prostate neoantigens and their uses
US20230035403A1 (en) 2020-07-06 2023-02-02 Janssen Biotech, Inc. Method For Determining Responsiveness To Prostate Cancer Treatment
EP4175721A1 (en) 2020-07-06 2023-05-10 Janssen Biotech, Inc. Prostate neoantigens and their uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE89743T1 (en) * 1986-08-18 1993-06-15 Dow Chemical Co CONJUGATE POETS STARS.
IL107715A0 (en) * 1992-11-25 1994-02-27 Baxter Int Water soluble non-immunogenic polyamide cross-linking agents
AU681735C (en) * 1993-07-14 2002-02-21 Regents Of The University Of California, The Self-assembling polynucleotide delivery system comprising dendrimer polycations
KR100357839B1 (en) * 1994-03-07 2003-08-02 더 다우 케미칼 캄파니 Bioactive and / or Targeted Dendrimer Conjugates
IT1270994B (en) * 1994-03-18 1997-05-26 Bracco Spa POLYOXYKYLIC STRUCTURE MACROMOLECULES WITH THEIR USE

Also Published As

Publication number Publication date
JPH10510822A (en) 1998-10-20
NO972868D0 (en) 1997-06-20
HUT77521A (en) 1998-05-28
FI972548A (en) 1997-06-23
EP0790837A1 (en) 1997-08-27
CA2206915A1 (en) 1996-06-27
FI972548A0 (en) 1997-06-16
NO972868L (en) 1997-08-19
AU4344696A (en) 1996-07-10
WO1996019240A1 (en) 1996-06-27

Similar Documents

Publication Publication Date Title
TJ328B (en) Interferron conjugates
DE69530493D1 (en) Ablationsgerät
DE69512030D1 (en) Cerebral-dilator
DE59503739D1 (en) Polymer-sensor
EP0765166A4 (en) Radiolabeled annexin-galactose conjugates
DE69502271D1 (en) Afterabtrennung
DE69429543D1 (en) Koagulationszange
DE69504528D1 (en) Quenchkühler
DE59503634D1 (en) Friercontainer
IL116456A0 (en) Oligonucleotide-dendrimer conjugates
DE59509661D1 (en) Heterocyclylbenzonitrile
AU122938S (en) Breadbox
DE59508136D1 (en) Phenylthio-oxazolin-derivate
DE69506730D1 (en) Differentialer antriebsmechanismus
ZA9510827B (en) Oligonucleotide-dendrimer conjugates
DE69504062D1 (en) Spandexlieferspule
DE59510739D1 (en) N-cyanoaryl-stickstoffheterocyclen
DE59503452D1 (en) Piezoresistiver widerstand
DE69502834D1 (en) Vinylperfluorcyclopropanpolymere
CA73798S (en) Air-purifier
CA73835S (en) Air-purifier
GB9422971D0 (en) Two part keepnet
ZA951608B (en) Inclusion complex
GB9400761D0 (en) Carbohydrate conjugates
GB9415017D0 (en) Golf-mate